GERON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.48 USD | -0.29% |
|
-8.66% | +64.93% |
| May. 03 | Wedbush Adjusts Geron's Price Target to $7 From $6, Keeps Outperform Rating | MT |
| May. 02 | Geron Shares Decline After Q1 Loss Widens | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GERON CORPORATION | Bio Therapeutic Drugs | -0.29% | -8.66% | +64.93% | +10.83% | +124.52% | 2.06B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- GERN Stock
- Charts Geron Corporation
- Comparison Chart
